Insider Trading: Illumina Inc (ILMN.O)
ILMN.O on Nasdaq
72.00USD
17 May 2013
72.00USD
17 May 2013
Price Change (% chg)
$2.35 (+3.37%)
$2.35 (+3.37%)
Prev Close
$69.65
$69.65
Open
$70.13
$70.13
Day's High
$72.42
$72.42
Day's Low
$69.65
$69.65
Volume
1,571,817
1,571,817
Avg. Vol
1,329,006
1,329,006
52-wk High
$77.11
$77.11
52-wk Low
$37.77
$37.77
| FLATLEY JAY T | Options Exercised: 0 | ||
| Trade Date: | Wednesday, 7 Nov 2012 | Price: | 4.30 |
| Title: | Chief Executive Officer | Shares Held: | 409,357 |
| Type Traded: | Direct | Net Change in Shares This Filing: | 0 |
Institutional Holders
| % Shares Owned: | 0.00% |
| # of Holders: | 435 |
| Total Shares Held: | 143,812,734 |
| 3 Mo. Net Change: | -324,873 |
| # New Positions: | 38 |
| # Closed Positions: | 62 |
| # Increased Positions: | 176 |
| # Reduced Positions: | 200 |
| # Net Buyers: | -24 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
William Rastetter |
64 | 2005 | Chairman of the Board |
Jay Flatley |
60 | 1999 | President, Chief Executive Officer, Director |
Marc Stapley |
43 | 2012 | Chief Financial Officer, Senior Vice President |
David Walt |
60 | 1998 | Chairman - Scientific Advisory Board, Independent Director |
Mostafa Ronaghi |
44 | 2008 | Chief Technology Officer, Senior Vice President |
Charles Dadswell |
2013 | Senior Vice President, General Counsel, Secretary | |
Gregory Heath |
55 | 2008 | Senior Vice President, General Manager - Diagnostics |
Christian Henry |
45 | 2012 | Senior Vice President, General Manager - Genetic Analysis |
Mark Lewis |
60 | 2012 | Senior Vice President, General Manager - Molecular Biology and PCR |
Matthew Posard |
46 | 2012 | Senior Vice President, General Manager - Translational and Consumer Genomics |
Paul Bianchi |
51 | 2012 | Senior Vice President - Human Resources |
Nicholas Naclerio |
52 | 2011 | Senior Vice President - Corporate and Venture Development |
Tristan Orpin |
47 | 2010 | Chief Commercial Officer, Senior Vice President |
A. Blaine Bowman |
66 | 2007 | Independent Director |
Daniel Bradbury |
51 | 2004 | Independent Director |
Karin Eastham |
63 | 2004 | Independent Director |
Robert Epstein |
57 | 2012 | Independent Director |
Paul Grint |
2005 | Independent Director | |
Gerald Moller |
69 | 2010 | Independent Director |
Roy Whitfield |
59 | 2007 | Independent Director |
Rebecca Chambers |
Senior Director - Investor Relations |

